Haemophilia patients' unmet needs and their expectations of the new extended half-life factor concentrates.
Sylvia von MackensenW KalninsJ KruckerJ WeissW MiesbachM AlbisettiI PabingerJ OldenburgPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2017)
The representative survey could show that although PWH were generally satisfied with their current FC, the majority would be willing to switch to EHL products assuming half-life is prolonged and has the same safety of the current FC.